StockNews.AI
TVGN
StockNews.AI
3 hrs

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston

1. Mittul Mehta to speak at Databricks World Tour on October 8, 2025. 2. Discussion focuses on using AI to scale precision immunotherapy. 3. Tevogen.AI's PredicTcell™ developed with Microsoft and Databricks.

3m saved
Insight
Article

FAQ

Why Bullish?

Mehta's participation highlights Tevogen's innovative approaches, potentially boosting investor confidence in its AI capabilities. Historically, similar engagements have positively influenced stock performance in tech-centric biotech firms.

How important is it?

The article highlights strategic engagement in the AI space relevant to Tevogen's growth, indicating a clear connection between innovative discussions and market interest.

Why Long Term?

Mehta's insights could enhance Tevogen's market positioning over time, aligning with the increasing demand for advanced therapeutics. Past examples show that consistent innovation exposure positively affects longer-term stock trajectories.

Related Companies

MSFTDBCVAC
WARREN, N.J., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that Mittul Mehta, Chief Information Officer of Tevogen and Head of Tevogen.AI, will participate as a panelist in the Startup Forum at the Databricks DATA + AI World Tour on October 8, 2025. The Startup Forum will feature insights from venture capital leaders and early-stage innovators on how they are scaling their companies with Databricks. Mehta will join industry peers including Chris Gervais, CTO of Codametrix, and Stavros Papadopoulos, CEO of TileDB, in a discussion moderated by Tony Pezzullo, Principal at SignalFire. Mehta will share perspectives on Tevogen.AI’s application of advanced data and AI technologies, including its PredicTcell™ platform, developed in collaboration with Microsoft and Databricks, to accelerate precision immunotherapy development. Databricks DATA + AI World Tour will take place at the Sheraton Boston Hotel. For more information please contact, communications@tevogen.com Contacts Tevogen Bio Communications T: 1 877 TEVOGEN, Ext 701 Communications@Tevogen.com A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b86622e6-99bc-4be9-8b77-537a3cb5e357

Related News